CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹754 Cr | ₹536 Cr | ₹288 Cr | ₹371 Cr | ₹315 Cr |
What is the latest Net Current Assets ratio of CONCORD BIOTECH ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹754 Cr |
Mar2023 | ₹536 Cr |
Mar2022 | ₹288 Cr |
Mar2021 | ₹371 Cr |
Mar2020 | ₹315 Cr |
How is Net Current Assets of CONCORD BIOTECH Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹754 Cr | 40.72 | |
Mar2023 | ₹536 Cr | 85.79 | |
Mar2022 | ₹288 Cr | -22.30 | |
Mar2021 | ₹371 Cr | 17.73 | |
Mar2020 | ₹315 Cr | - |
Compare Net Current Assets of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹22,720.2 Cr | 9.9% | 2.4% | 44.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,228.0 Cr | -2.4% | -7.2% | 27.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹148,023.0 Cr | 0% | -9.2% | 61.5% | Stock Analytics | |
CIPLA | ₹119,474.0 Cr | 6% | -3.8% | 10.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,599.0 Cr | 1.7% | -11.4% | 2.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,604.7 Cr | 5.2% | -2.1% | 26.1% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | 9.9% |
2.4% |
44.8% |
SENSEX | 1.7% |
-1.3% |
7.7% |
You may also like the below Video Courses